Indian pharmaceuticals major Cipla Ltd on Friday said that its board had approved a proposal to raise up to Rs3,000 crore through sale of equity shares or equity linked instruments, the company said in a stock exchange filing.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
